General Announcement::Submission of Annual Report FY 2020-21

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Aug-2021 00:34:43
Status
New
Announcement Sub Title
Submission of Annual Report FY 2020-21
Announcement Reference
SG210828OTHRUK4Z
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
27/08/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
Submission of Annual Report under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments

SGX_AR_2021.pdf
Total size =9616K